Across TCGA pan-cancer cohorts, LINC00111 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC00111 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC00111 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00111 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CHOL show a favorable association.
KIRC, ACC, and THCA are the cancer types where LINC00111 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.